Pfizer is testing an extra dose of its COVID-19 vaccine for babies and preschoolers after preliminary research hinted the usual two doses wouldn't be enough.
Pfizer reports that a lower dose of its COVID-19 vaccine did not produce a potent immune response in children 2 to 4. Here’s what we know.
For children younger than 5, Pfizer is testing an even smaller dose, just 3 micrograms or one-tenth of the adult dose. Researchers analyzed a subset of youngsters in the study a month after their second dose to see if the tots developed levels of virus-fighting antibodies that were similar to teens and young adults who get the regular shots.
The very low-dose shots appeared to work in youngsters under age 2, who produced similar antibody levels. But the immune response in 2- to 4-year-olds was lower than the study required, Pfizer vaccine research chief Kathrin Jansen said Friday in a call with investors. Rather than trying a higher-dose shot for the preschoolers, Pfizer decided to expand the study to evaluate three of the very low-dose shots in all the study participants — from 6 months up to age 5. That third shot will come at least two months after the youngsters’ second dose.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Covid-19: Nisra records increase in Covid-related deathsThe agency's Covid deaths total, based on mentions of the virus on death certificates, is 3,937.
Les mer »
Pfizer Requests Full Approval For Covid-19 Vaccine For 12- To 15-Year-OldsThe pharmaceutical company said in November its vaccine gave the age group 100% long-term protection against the virus.
Les mer »
Pfizer is testing a 3rd COVID-19 vaccine dose in young kidsPfizer and BioNTech are testing a third dose of their COVID-19 vaccine in an ongoing trial of children ages 6 months to under 5 years, the companies announced F
Les mer »
Pfizer Testing Extra COVID-19 Vaccine Dose For Children Under 5The addition of an extra dose came after a preliminary analysis found 2- to 4-year-olds didn't have as strong an immune response as expected.
Les mer »
Pfizer Requests Full Approval For Covid-19 Vaccine For 12- To 15-Year-OldsThe pharmaceutical company said in November its vaccine gave the age group 100% long-term protection against the virus.
Les mer »
CDC Recommends Pfizer, Moderna Covid-19 Vaccines Over J&J’sHealth authorities said the rate of a rare but serious blood-clotting disorder associated with the Johnson & Johnson shot is higher than previously detected.
Les mer »